These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 8377628)

  • 1. Hypertension: a review with emphasis on therapeutics with ACE inhibitors.
    Preuss HG; Gondal JA; Burris JF
    Md Med J; 1993 Jun; 42(6):557-64. PubMed ID: 8377628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypertension mega-trials with cardiovascular end points: effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.
    Kjeldsen SE; Julius S
    Am Heart J; 2004 Nov; 148(5):747-54. PubMed ID: 15523303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Choosing a first-line drug in the management of elevated blood pressure: what is the evidence? 3: Angiotensin-converting-enzyme inhibitors.
    Wright JM
    CMAJ; 2000 Aug; 163(3):293-6. PubMed ID: 10951729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Angiotensin converting enzyme inhibitors for hypertension].
    Kobusiak-Prokopowicz M
    Pol Merkur Lekarski; 1997 Jan; 2(7):66-70. PubMed ID: 9296907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Angiotensin II antagonists versus ACE inhibitors in the treatment of raised blood pressure].
    Andersen RS; Christensen S
    Ugeskr Laeger; 2001 Dec; 163(50):7036-9. PubMed ID: 11794033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of hypertension in patients with chronic kidney disease and diabetes mellitus.
    Palmer BF
    Am J Med; 2008 Aug; 121(8 Suppl):S16-22. PubMed ID: 18638614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age-related effects of angiotensin converting enzyme inhibitors.
    Breckenridge A
    J Cardiovasc Pharmacol; 1988; 12 Suppl 8():S100-4. PubMed ID: 2469889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Is there a need for direct renin inhibitors?].
    Grossman E
    Harefuah; 2008 Mar; 147(3):216-7, 278. PubMed ID: 18488862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of beta-blockade and ACE inhibitors in the treatment of hypertension.
    Prichard BN; Saul PA
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S81-5. PubMed ID: 11527141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypertension in elderly--an overview.
    Bhattacharyya A; Das P
    J Indian Med Assoc; 1999 Mar; 97(3):96-101. PubMed ID: 10652909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy.
    Khan NA; McAlister FA; Campbell NR; Feldman RD; Rabkin S; Mahon J; Lewanczuk R; Zarnke KB; Hemmelgarn B; Lebel M; Levine M; Herbert C;
    Can J Cardiol; 2004 Jan; 20(1):41-54. PubMed ID: 14968142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The use of angiotensin converting enzyme inhibitors in practice].
    Zschiedrich H
    Arzneimittelforschung; 1993 Feb; 43(2A):271-3. PubMed ID: 8498977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RAS inhibition in hypertension.
    Ibrahim MM
    J Hum Hypertens; 2006 Feb; 20(2):101-8. PubMed ID: 16397519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Are all antihypertensive drugs renoprotective?].
    Wolf S; Risler T
    Herz; 2004 May; 29(3):248-54. PubMed ID: 15167950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in hypertension due to primary aldosteronism: a case for exclusion.
    Bubbar CD; Blackburn DF; Wilson MP; Wilson TW
    Ann Pharmacother; 2007 Jan; 41(1):129-32. PubMed ID: 17179189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased vascular compliance/decreased cardiovascular risk: what the studies tell us.
    Frishman WH
    Heart Dis; 2000; 2(5):384-8. PubMed ID: 11728287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
    Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
    J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Oral inhibitors of renin and their potential use as therapeutic agents in treating hypertension].
    Abassi Z; Armaly Z; Nakhoul F; Hoffman A
    Harefuah; 2008 Jun; 147(6):536-42, 573. PubMed ID: 18693632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.